<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet href="/tresources/styles/tendenci-rss.xsl" type="text/xsl" media="screen"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>Liver Specialists of Texas - Content Managers</title>
<link>http://www.texasliver.com</link>
<description>Liver Specialists of Texas Content Managers RSS feed. .</description>
<copyright>Copyright 2010 Liver Specialists of Texas</copyright>
<generator>Tendenci Software by Schipul - The Web Marketing Company</generator>
<language>en-us</language>
<webMaster>noemail@texasliver.com</webMaster>
<pubDate>Tue, 07 Sep 2010 13:52:28 GMT</pubDate>
		<item>
			<category>Content Managers</category>
			<link>http://www.texasliver.com/en/cms/143/</link>
			<title>Fatty Liver</title>
			<description>Some individuals can develop fatty liver. Most people who do not abuse alcohol and have fatty liver are  obese. The term that has been accepted is non-alcoholic fatty liver disease (NAFLD). Fatty liver is called steatosis, and fatty liver with liver inflammation is called or steatohepatitis. Steatosis and steatohepatitis can be caused by alcohol and other drugs and can also sometimes occur in patients with diabetes mellitus. The factors that determine who will develop fatty liver are not known. Some mildly obese and occasional non-obese patients will develop fatty liver while some who are severely obese will not. There is a direct relationship between the metabolic syndrome and NAFLD.  Patients with fatty liver or steatohepatitis usually present to a physician with unexplained elevations in the  serum aminotransferase (ALT/AST) activities. Serum alkaline phosphatase and gamma-glutamyltranspeptidase (GGTP) activities can also be elevated. The patient is usually 10% or more above...

</description>
			<guid isPermaLink="false">http://www.texasliver.com/en/cms/143/</guid>
			<pubDate>Fri, 16 Nov 2007 21:08:14 GMT</pubDate>
		</item>
</channel>
</rss>
